{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:54:12Z","timestamp":1767981252360,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11096-014-9955-4","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T05:10:49Z","timestamp":1403154649000},"page":"766-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent"],"prefix":"10.1007","volume":"36","author":[{"given":"Geraldo B.","family":"Silva Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Patr\u00edcia F.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda X.","family":"Couto Bem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia P.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gdayllon C.","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice M. C.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia M. H. A.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre V.","family":"Lib\u00f3rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth F.","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"issue":"6","key":"9955_CR1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1590\/S0034-89102005000600012","volume":"39","author":"MM Loureiro","year":"2005","unstructured":"Loureiro MM, Rozenfeld S. Epidemiology of sickle cell disease hospital admissions in Brazil. Rev Sa\u00fade P\u00fablica. 2005;39(6):943\u20139.","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"9955_CR2","first-page":"397","volume":"43","author":"H Josephs","year":"1928","unstructured":"Josephs H. Clinical aspects of sickle cell anemia. Bull Johns Hopkins Hosp. 1928;43:397\u20138.","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"9","key":"9955_CR3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI103360","volume":"35","author":"HG Keitel","year":"1956","unstructured":"Keitel HG, Thompson D, Itano HA. Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest. 1956;35(9):998\u20131007.","journal-title":"J Clin Invest"},{"issue":"1","key":"9955_CR4","first-page":"39","volume":"53","author":"AP Crosley","year":"1961","unstructured":"Crosley AP, Strickland WH. Renal function in sickle cell anemia\u2014a case report and review of the literature. J Natl Med Assoc. 1961;53(1):39\u201340.","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"9955_CR5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","volume":"122","author":"G Tsaras","year":"2009","unstructured":"Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122(6):507\u201312.","journal-title":"Am J Med"},{"issue":"2","key":"9955_CR6","doi-asserted-by":"crossref","first-page":"c98","DOI":"10.1159\/000213897","volume":"112","author":"H Abo-Zenah","year":"2009","unstructured":"Abo-Zenah H, Moharram M, El Nahas AM. Cardiorenal risk prevalence in sickle cell hemoglobinopathy. Nephron Clin Pract. 2009;112(2):c98\u2013106.","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"9955_CR7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-011-1327-8","volume":"90","author":"GB Silva Da Jr","year":"2011","unstructured":"Da Silva GB Jr, Lib\u00f3rio AB, Daher Ede F. New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy. Ann Hematol. 2011;90(12):1371\u20139.","journal-title":"Ann Hematol"},{"key":"9955_CR8","unstructured":"Wang WC. Sickle cell anemia and other sickling syndromes. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means Jr RT. Wintrobe\u2019s clinical hematology, 12th edition. Philadelphia: Lippincott Williams and Wilkins, p. 1038\u20131082, 2009. ISBN: 978-0-7817-6507-7"},{"key":"9955_CR9","unstructured":"Saunthararajah Y, Vichinsky EP. Sickle cell disease\u2014clinical features and management. In: Hoffman\u2014Hematology: basic principles and practice. Oxford: Churchill Livingstone, 5th edn, p. 577\u2013601, 2008. ISBN: 978-0443067150."},{"issue":"9757","key":"9955_CR10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018\u201331.","journal-title":"Lancet"},{"issue":"3","key":"9955_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/ehm.10.22","volume":"3","author":"AM Brandow","year":"2010","unstructured":"Brandow AM, Panepinto JA. Hydroxycarbamide use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol. 2010;3(3):255\u201360.","journal-title":"Expert Rev Hematol"},{"issue":"26","key":"9955_CR12","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE. How I use Hydroxycarbamide to treat young patients with sickle cell anemia. Blood. 2010;115(26):5300\u201311.","journal-title":"Blood"},{"issue":"12","key":"9955_CR13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","volume":"148","author":"OW Brawley","year":"2008","unstructured":"Brawley OW, Cornelius LJ, Edwards LR, Northington Gamble V, Green BL, Inturrisi C, et al. National institutes of health consensus development conference statement: hydroxycarbamide treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932\u20138.","journal-title":"Ann Intern Med"},{"issue":"9","key":"9955_CR14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"4","key":"9955_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1590\/S1516-84842010000400002","volume":"32","author":"C Lobo","year":"2010","unstructured":"Lobo C. Sickle cell disease\u2014a serious problem for public health worldwide. Rev Bras Hematol Hemoter. 2010;32(4):280\u20131.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"9955_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOH.0b013e328351c35f","volume":"19","author":"P Bartolucci","year":"2012","unstructured":"Bartolucci P, Galact\u00e9ros F. Clinical management of adult sickle-cell disease. Curr Opin Hematol. 2012;19(3):149\u201355.","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"9955_CR17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","volume":"88","author":"B Aygun","year":"2013","unstructured":"Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE. Hydroxycarbamide treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol. 2013;88(2):116\u20139.","journal-title":"Am J Hematol"},{"issue":"6","key":"9955_CR18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/pbc.21520","volume":"50","author":"O Alvarez","year":"2008","unstructured":"Alvarez O, Lopez-Mitnik G, Zilleruelo G. Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer. 2008;50(6):1236\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"9955_CR19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/pbc.20296","volume":"45","author":"CD Fitzhugh","year":"2005","unstructured":"Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxycarbamide therapy for children with sickle nephropathy. Pediatr Blood Cancer. 2005;45(7):982\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"9955_CR20","first-page":"009191","volume":"3","author":"TH Sasongko","year":"2013","unstructured":"Sasongko TH, Nagalla S, Ballas SK. Angiotension-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Datab Syst Rev. 2013;3:009191.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"5","key":"9955_CR21","first-page":"903","volume":"21","author":"A Aleem","year":"2010","unstructured":"Aleem A. Proteinuria in adult Saudi patients with sickle cell disease is not associated with identifiable risk factors. Saudi J Kidney Dis Transpl. 2010;21(5):903\u20138.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"9955_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000355748","volume":"38","author":"GB Silva Junior","year":"2013","unstructured":"Silva Junior GB, Vieira AP, Couto Bem AX, Alves MP, Meneses GC, Martins AM, et al. Renal tubular dysfunction in sickle cell disease. Kidney Blood Press Res. 2013;38(1):1\u201310.","journal-title":"Kidney Blood Press Res"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-9955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-014-9955-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-9955-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:48Z","timestamp":1559354088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-014-9955-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9955"],"URL":"https:\/\/doi.org\/10.1007\/s11096-014-9955-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}